MedTrace Logo

Efficacy and Safety of Near Infrared Light Therapy for Alzheimer's Disease

NCT06008639 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-09-06

No results posted yet for this study

Summary

To explore the efficacy and safety of near infrared light therapy for Alzheimer's disease. Each subject will be numbered and their medical records will be established. The subjects will be randomly assigned to the treatment group or the control group for 30 minutes/day (5-6 days a week) for 4 months while the treatment group is active settings and the control group is sham settings.Follow-up visits will be conducted at 2 months, 4 months and 2 months after treatment. At each follow-up, scale assessment, blood, MRI, and EEG were observed

Conditions

  • Mild to Moderate Alzheimer's Disease

Interventions

DEVICE

treatment group-Device: NirsCure - Active NirsCure - Active settings

Treatment was performed once a day,5-6 times a week for 16 weeks.

DEVICE

placebo group-Device: NirsCure - Sham NirsCure - Sham settings

Treatment was performed once a day,5-6 times a week for 16 weeks.

Sponsors & Collaborators

  • Rehabilitation Hospital Affiliated to National Research Center for Rehabilitation Technical Aids

    collaborator UNKNOWN

  • First Affiliated Hospital of Chongqing Medical University

    collaborator OTHER

  • Danyang Huichuang Medical Equipment Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Ping Ze Lv · Rehabilitation Hospital Affiliated to National Research Center for Rehabilitation Technical Aids

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06008639 on ClinicalTrials.gov